Literature DB >> 3601078

Cognitive deficits and clinical diagnosis of Alzheimer's disease.

F J Huff, J T Becker, S H Belle, R D Nebes, A L Holland, F Boller.   

Abstract

We used cognitive deficits detected by neuropsychological testing to evaluate clinical diagnosis of Alzheimer's disease. Deficits were defined with respect to performance of control subjects according to procedural guidelines set by a NINCDS-ADRDA Work Group. The most frequent deficits were in recent memory and lexical-semantic language abilities. Clinical diagnosis of Alzheimer's disease was compared with diagnosis based on a criterion of two or more cognitive deficits both on initial neuropsychological testing and on testing repeated a year later in some subjects. Initial clinical diagnosis identified 96% of cases who met the criterion when first tested and 100% of those with multiple deficits at follow-up. Specificity with respect to the criterion was 86% on initial testing and 89% at follow-up. These findings support the validity of clinical diagnosis of Alzheimer's disease using the NINCDS-ADRDA criteria.

Entities:  

Mesh:

Year:  1987        PMID: 3601078     DOI: 10.1212/wnl.37.7.1119

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  The cerebral localization of neuropsychological impairment in Alzheimer's disease: a SPECT study.

Authors:  G Goldenberg; I Podreka; E Suess; L Deecke
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

3.  Effects of age on measures of complex working memory span in the beagle dog (Canis familiaris) using two versions of a spatial list learning paradigm.

Authors:  P Dwight Tapp; Christina T Siwak; Jimena Estrada; Daniel Holowachuk; Norton W Milgram
Journal:  Learn Mem       Date:  2003 Mar-Apr       Impact factor: 2.460

4.  Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).

Authors:  Carola Romberg; Mark P Mattson; Mohamed R Mughal; Timothy J Bussey; Lisa M Saksida
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

5.  Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Authors:  Montse Alegret; Mercè Boada-Rovira; Georgina Vinyes-Junqué; Sergi Valero; Ana Espinosa; Isabel Hernández; Gemma Modinos; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga
Journal:  J Clin Exp Neuropsychol       Date:  2009-01-14       Impact factor: 2.475

6.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.

Authors:  U Spampinato; M O Habert; J L Mas; M C Bourdel; M Ziegler; J de Recondo; S Askienazy; P Rondot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

7.  The underlying mechanisms of semantic memory loss in Alzheimer's disease and semantic dementia.

Authors:  Sean L Rogers; Rhonda B Friedman
Journal:  Neuropsychologia       Date:  2007-08-22       Impact factor: 3.139

8.  Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia.

Authors:  John Listerud; Chivon Powers; Peachie Moore; David J Libon; Murray Grossman
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

Review 9.  Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.

Authors:  J Jolles; F R Verhey; W J Riedel; P J Houx
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

10.  Dementia and driving.

Authors:  D O'Neill; K Neubauer; M Boyle; J Gerrard; D Surmon; G K Wilcock
Journal:  J R Soc Med       Date:  1992-04       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.